Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
199 Results Found
AHRMM LUC Comments to the FDA’s Draft Guidance for Select Updates for Unique Device Identification: Policy Regarding Global Unique Device Identification Database Requirements for Certain Devices
The AHRMM LUC members submitted comments and recommendations to the FDA's Draft Guidance for Select Updates for Unique Device Identification: Policy Regarding Global Unique Device Identification Database Requirements for Certain Devices. They recommend that information related to all Class I Medical Devices be included in the GUDID without exception.
AHA Comments on CMS Proposal on Accrediting Organization Oversight
AHA comments on CMS’ proposals to strengthen the agency’s oversight of accrediting organizations.
AHA Letter to UnitedHealthcare RE: Molecular Pathology Reimbursement Policy
AHA addresses UnitedHealthcare’s implementation of its Molecular Pathology Reimbursement Policy on April 1, 2024.
Senate Passes AHA-supported Legislation Repealing Antitrust Exemption for Health Insurers
The Senate passed by voice vote the Competitive Health Insurance Reform Act (H.R. 1418/S. 350), AHA-supported legislation that repeals the McCarran-Ferguson antitrust exemption available to commercial health insurers for anticompetitive conduct.
Rural Advocacy Agenda 2024
The AHA supports policies and legislation that enable rural hospitals to care for their communities. The Rural Advocacy Agenda outlines some key areas of focus for our 2024 advocacy agenda.
Liability Reform
The increased costs that result from the current flawed medical liability system not only hinder access to affordable health care, they also threaten the stability of the health care field, which employed 5.7 million people in 2015, and continues to be one of the largest sources of private-sector jobs.
HHS Finalizes Changes to Information-sharing Requirements for Addiction Treatment
The HHS Office for Civil Rights and the Substance Abuse and Mental Health Services Administration Feb. 8 finalized modifications of certain provisions of part 2 of title 42 of the Code of Federal Regulations, commonly known as 42 CFR Part 2 (or Part 2), to align requirements for patient records regarding treatment for substance use disorder (SUD) with those in effect under the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule.
CMS memo: Canopy and overhang sprinkler requirements
Advisory
This CMS memo clarifies policy on the use of the FSES when determining Life Safety Code compliance where canopies or overhangs are not sprinklered.
Rural Regulatory Policy
Medicare policy changes and payment adjustments often have significant and problematic consequences for rural providers. AHA is sensitive to the administrative burden and cost created by rules that fail to consider the unique circumstances of small or rural community hospitals.